Search Results - "Zabetian, C P"

Refine Results
  1. 1

    A clinic-based study of the LRRK2 gene in parkinson disease yields new mutations by ZABETIAN, C. P, SAMII, A, MOSLEY, A. D, ROBERTS, J. W, LEIS, B. C, YEAROUT, D, RASKIND, W. H, GRIFFITH, A

    Published in Neurology (13-09-2005)
    “…Referral-based studies indicate that a mutation (G2019S) in exon 41 of the LRRK2 gene might be a common cause of Parkinson disease (PD). The authors sequenced…”
    Get full text
    Journal Article
  2. 2

    Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology by Cubells, J F, Zabetian, C P

    Published in Psychopharmacology (01-08-2004)
    “…Norepinephrine (NE) is a key neurotransmitter in the central and peripheral nervous systems. Dopamine beta-hydroxylase (DbetaH) catalyzes the synthesis of NE…”
    Get full text
    Journal Article
  3. 3

    A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2 by KAY, D. M, STEVENS, C. F, HIGGINS, D. S, GANCHER, S, MOSES, L, ZAREPARSI, S, POORKAJ, P, BIRD, T, NUTT, J, SCHELLENBERG, G. D, PAYAMI, H, HAMZA, T. H, MONTIMURRO, J. S, ZABETIAN, C. P, FACTOR, S. A, SAMII, A, GRIFFITH, A, ROBERTS, J. W, MOLHO, E. S

    Published in Neurology (28-09-2010)
    “…To perform a comprehensive population genetic study of PARK2. PARK2 mutations are associated with juvenile parkinsonism, Alzheimer disease, cancer, leprosy,…”
    Get full text
    Journal Article
  4. 4

    Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers by AASLY, J. O, SHI, M, KIM, H. M, LEVERENZ, J. B, GINGHINA, C, ARMALY, J, EDWARDS, K. L, SNAPINN, K. W, STOESSL, A. J, ZHANG, J, SOSSI, V, STEWART, T, JOHANSEN, K. K, WSZOLEK, Z. K, UITTI, R. J, HASEGAWA, K, YOKOYAMA, T, ZABETIAN, C. P

    Published in Neurology (03-01-2012)
    “…The goal of the current investigation was to examine a cohort of symptomatic and asymptomatic LRRK2 mutation carriers, in order to address whether the reported…”
    Get full text
    Journal Article
  5. 5

    Human PON1, a biomarker of risk of disease and exposure by Furlong, C.E., Suzuki, S.M., Stevens, R.C., Marsillach, J., Richter, R.J., Jarvik, G.P., Checkoway, H., Samii, A., Costa, L.G., Griffith, A., Roberts, J.W., Yearout, D., Zabetian, C.P.

    Published in Chemico-biological interactions (06-09-2010)
    “…Human paraoxonase 1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that exhibits a broad substrate specificity. In addition to protecting…”
    Get full text
    Journal Article
  6. 6

    Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease by ZABETIAN, C. P, MORINO, H, ROBERTS, J. W, YEAROUT, D, SAMII, A, KAWAKAMI, H, UJIKE, H, YAMAMOTO, M, ODA, M, MARUYAMA, H, IZUMI, Y, KAJI, R, GRIFFITH, A, LEIS, B. C

    Published in Neurology (22-08-2006)
    “…LRRK2 G2019S is the most common known cause of Parkinson disease (PD) in patients of European origin, but little is known about its distribution in other…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease by Kelly, V.E, Johnson, C.O, McGough, E.L, Shumway-Cook, A, Horak, F.B, Chung, K.A, Espay, A.J, Revilla, F.J, Devoto, J, Wood-Siverio, C, Factor, S.A, Cholerton, B, Edwards, K.L, Peterson, A.L, Quinn, J.F, Montine, T.J, Zabetian, C.P, Leverenz, J.B

    Published in Parkinsonism & related disorders (01-07-2015)
    “…Abstract Introduction Research suggests an association between global cognition and postural instability/gait disturbance (PIGD) in Parkinson disease (PD), but…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    A genetic basis for the variable effect of smoking/nicotine on Parkinson’s disease by Hill-Burns, E M, Singh, N, Ganguly, P, Hamza, T H, Montimurro, J, Kay, D M, Yearout, D, Sheehan, P, Frodey, K, Mclear, J A, Feany, M B, Hanes, S D, Wolfgang, W J, Zabetian, C P, Factor, S A, Payami, H

    Published in The pharmacogenomics journal (01-12-2013)
    “…Prior studies have established an inverse association between cigarette smoking and the risk of developing Parkinson’s disease (PD), and currently, the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    511 PRAZOSIN IMPROVES NIGHTMARES AND SLEEP DISTURBANCE AND DOES NOT WORSEN DAYTIME SYMPTOMS IN POSTTRAUMATIC STRESS DISORDER by Wander, P. L., Raskind, M. A., Zabetian, C. P., Warren, D. J., Kumata, J., Peskind, E. R.

    Published in Journal of investigative medicine (01-01-2006)
    “…BackgroundIn an ongoing parallel-group double-blind placebo-controlled trial at the VA Puget Sound Health Care System, the efficacy of the alpha-1 adrenergic…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Functional variants at CYP2A6: New genotyping methods, population genetics, and relevance to studies of tobacco dependence by Zabetian, Cyrus P., Gelernter, Joel, Cubells, Joseph F.

    Published in American journal of medical genetics (09-10-2000)
    “…Cytochrome P450CYP2A6 (CYP2A6) is the predominant enzyme responsible for the metabolism of nicotine to cotinine. Two variants have been identified that encode…”
    Get full text
    Journal Article
  20. 20

    Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis by Factor, Stewart A, Steenland, N Kyle, Higgins, Donald S, Molho, Eric S, Kay, Denise M, Montimurro, Jennifer, Rosen, Ami R, Zabetian, Cyrus P, Payami, Haydeh

    “…ObjectiveTo test the hypothesis that postural instability with falling (PIF) and freezing of gait (FOG) are distinct subtypes of the postural instability/gait…”
    Get full text
    Journal Article